1. Home
  2. NRXP vs SIDU Comparison

NRXP vs SIDU Comparison

Compare NRXP & SIDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • SIDU
  • Stock Information
  • Founded
  • NRXP 2015
  • SIDU 2012
  • Country
  • NRXP United States
  • SIDU United States
  • Employees
  • NRXP N/A
  • SIDU N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • SIDU Telecommunications Equipment
  • Sector
  • NRXP Health Care
  • SIDU Telecommunications
  • Exchange
  • NRXP Nasdaq
  • SIDU Nasdaq
  • Market Cap
  • NRXP 32.6M
  • SIDU 30.0M
  • IPO Year
  • NRXP N/A
  • SIDU 2021
  • Fundamental
  • Price
  • NRXP $3.21
  • SIDU $1.74
  • Analyst Decision
  • NRXP Strong Buy
  • SIDU
  • Analyst Count
  • NRXP 4
  • SIDU 0
  • Target Price
  • NRXP $28.50
  • SIDU N/A
  • AVG Volume (30 Days)
  • NRXP 202.4K
  • SIDU 591.5K
  • Earning Date
  • NRXP 08-13-2025
  • SIDU 08-18-2025
  • Dividend Yield
  • NRXP N/A
  • SIDU N/A
  • EPS Growth
  • NRXP N/A
  • SIDU N/A
  • EPS
  • NRXP N/A
  • SIDU N/A
  • Revenue
  • NRXP N/A
  • SIDU $3,860,985.00
  • Revenue This Year
  • NRXP N/A
  • SIDU $144.49
  • Revenue Next Year
  • NRXP N/A
  • SIDU N/A
  • P/E Ratio
  • NRXP N/A
  • SIDU N/A
  • Revenue Growth
  • NRXP N/A
  • SIDU N/A
  • 52 Week Low
  • NRXP $1.10
  • SIDU $1.14
  • 52 Week High
  • NRXP $6.01
  • SIDU $7.65
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 51.07
  • SIDU 53.71
  • Support Level
  • NRXP $3.12
  • SIDU $1.64
  • Resistance Level
  • NRXP $3.53
  • SIDU $1.98
  • Average True Range (ATR)
  • NRXP 0.18
  • SIDU 0.12
  • MACD
  • NRXP -0.05
  • SIDU 0.01
  • Stochastic Oscillator
  • NRXP 41.82
  • SIDU 42.86

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About SIDU Sidus Space Inc.

Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.

Share on Social Networks: